Revenue
2018
2019
2020
2021
2022
2023
2024
2025
GeoVax Labs, Inc. (GOVX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5M | $4.0M | $0 | $81,526 | $385,501 | $1.8M | $1.2M | $963,203 | $1.1M | $828,918 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $18.1M | $23.7M | $20.7M | $9.1M | $15.6M | $2.4M | $1.9M | $1.9M | $2.0M | $2.0M | $1.7M | $1.8M | $2.9M | $3.0M | $4.3M | $4.8M | $4.1M | — | — | — | — | — | — | — |
| Operating expenses | $24.1M | $29.1M | $26.7M | $14.1M | $19.1M | $4.6M | $3.5M | $3.5M | $3.2M | $4.1M | $3.1M | $3.6M | $4.7M | $4.8M | $7.2M | $8.0M | $7.0M | — | — | — | — | — | — | — |
| Operating income | −$21.6M | −$25.1M | −$26.7M | −$14.0M | −$18.7M | −$2.8M | −$2.4M | −$2.6M | −$2.2M | −$3.3M | −$2.7M | −$2.7M | −$2.3M | −$2.1M | −$2.3M | −$2.8M | −$3.3M | — | — | — | — | — | — | — |
| EBITDAderived | −$21.6M | −$25.0M | −$26.7M | −$14.0M | −$18.7M | −$2.8M | −$2.4M | −$2.5M | −$2.1M | −$3.2M | −$2.7M | −$2.7M | −$2.2M | −$2.0M | −$2.2M | −$2.7M | −$3.2M | — | — | — | — | — | — | — |
| Net income | −$21.5M | −$25.0M | −$26.0M | −$14.0M | −$18.6M | −$3.0M | −$2.4M | −$2.6M | −$2.2M | −$3.3M | −$2.7M | −$2.7M | −$2.3M | −$2.1M | −$2.3M | −$2.7M | −$3.3M | −$3.7M | −$4.2M | −$584,166 | −$1.6M | −$2.4M | −$947,804 | −$618,137 |
| Basic EPSper diluted share | -$22.40 | -$120.46 | -$14.29 | -$12.39 | -$3.04 | -$2.14 | -$781.87 | -$15,610.33 | -$0.03 | -$0.08 | -$0.08 | -$0.10 | -$0.11 | -$0.12 | -$0.15 | -$0.18 | -$0.22 | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | — | — | — | — | -$3.04 | -$2.14 | -$781.87 | -$15,610.33 | -$0.03 | -$0.08 | -$0.08 | -$0.10 | -$0.11 | -$0.12 | -$0.15 | -$0.18 | -$0.22 | — | — | — | — | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 17, 2025Form 4 | SPENCER JOHN N JRDirector | BuyCommon Stock | 10.0K | $0.55 | $5.5K | 21.4K |
| Aug 7, 2025Form 4 | McKee Kelly T. Jr.Chief Medical Officer | BuyCommon Stock | 1.1K | $0.67 | $741.69 | 3.5K |
| Apr 10, 2025Form 4 | SPENCER JOHN N JRDirector | BuyCommon Stock | 10.0K | $0.98 | $9.8K | 11.4K |
| Apr 10, 2025Form 4 | Sharkey John W.VP, Business Development | BuyCommon Stock | 6.0K | $0.99 | $5.9K | 6.2K |
| Apr 1, 2025Form 4 | DODD DAVID APresident, CEO | BuyCommon Stock | 10.0K | $1.08 | $10.8K | 36.7K |